These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26849938)

  • 1. Neurobehavioral effects of liraglutide and sitagliptin in experimental models.
    Kamble M; Gupta R; Rehan HS; Gupta LK
    Eur J Pharmacol; 2016 Mar; 774():64-70. PubMed ID: 26849938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of liraglutide on depressive behavior in a mouse depression model and cognition in the probe trial of Morris water maze test.
    Seo MK; Jeong S; Seog DH; Lee JA; Lee JH; Lee Y; McIntyre RS; Park SW; Lee JG
    J Affect Disord; 2023 Mar; 324():8-15. PubMed ID: 36566932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
    Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
    Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats.
    Sharma AN; Pise A; Sharma JN; Shukla P
    Metab Brain Dis; 2015 Jun; 30(3):719-30. PubMed ID: 25380665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline.
    Gault VA; Lennox R; Flatt PR
    Diabetes Obes Metab; 2015 Apr; 17(4):403-13. PubMed ID: 25580570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Emotional Motivational Disorders in Rats as a Result of Diprotin A and Sitagliptin Administration in the First Postnatal Week].
    Krupina NA; Khlebnikova NN; Orlova IN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2016 May; 66(3):367-381. PubMed ID: 30695419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice.
    Bahi A; Al Mansouri S; Al Memari E; Al Ameri M; Nurulain SM; Ojha S
    Physiol Behav; 2014 Aug; 135():119-24. PubMed ID: 24930711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment.
    Ebrahimi-Ghiri M; Nasehi M; Zarrindast MR
    Behav Brain Res; 2019 May; 364():296-302. PubMed ID: 30797851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
    Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
    Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension.
    Wang J; Yu M; Xu J; Cheng Y; Li X; Wei G; Wang H; Kong H; Xie W
    J Biomed Sci; 2019 Jan; 26(1):6. PubMed ID: 30634956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of forced exercise against nicotine-induced anxiety, depression and cognition impairment in rat.
    Motaghinejad M; Fatima S; Karimian M; Ganji S
    J Basic Clin Physiol Pharmacol; 2016 Jan; 27(1):19-27. PubMed ID: 26512426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
    Xu J; Wang J; Cheng Y; Li X; He M; Zhu J; Han H; Wei G; Kong H; Xie W; Wang H; Zuo X
    Biomed Res Int; 2018; 2018():1864107. PubMed ID: 29607314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of Scopolamine-Induced Amnesic, Anxiolytic and Antidepressant Effects of
    Malik H; Javaid S; Fawad Rasool M; Samad N; Rizwan Ahamad S; Alqahtani F; Imran I
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32210162
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurochemical modulation involved in the beneficial effect of liraglutide, GLP-1 agonist on PTZ kindling epilepsy-induced comorbidities in mice.
    Koshal P; Kumar P
    Mol Cell Biochem; 2016 Apr; 415(1-2):77-87. PubMed ID: 26965494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models.
    Scheich B; Gaszner B; Kormos V; László K; Ádori C; Borbély É; Hajna Z; Tékus V; Bölcskei K; Ábrahám I; Pintér E; Szolcsányi J; Helyes Z
    Neuropharmacology; 2016 Feb; 101():204-15. PubMed ID: 26387439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial.
    Pratley RE; Nauck M; Bailey T; Montanya E; Cuddihy R; Filetti S; Thomsen AB; Søndergaard RE; Davies M;
    Lancet; 2010 Apr; 375(9724):1447-56. PubMed ID: 20417856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two genetic animal models in behavioral tests of anxiety and depression.
    Hinojosa FR; Spricigo L; Izídio GS; Brüske GR; Lopes DM; Ramos A
    Behav Brain Res; 2006 Mar; 168(1):127-36. PubMed ID: 16324754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis.
    Citraro R; Iannone M; Leo A; De Caro C; Nesci V; Tallarico M; Abdalla K; Palma E; Arturi F; De Sarro G; Constanti A; Russo E
    Brain Res Bull; 2019 Nov; 153():133-142. PubMed ID: 31470253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.